Efficacy of Prolonged-Release Melatonin 2 mg (PRM 2 mg) Prescribed for Insomnia in Hospitalized Patients for COVID-19: A Retrospective Observational Study

Can melatonin reduce the severity of COVID-19 pandemic?

(2020) Alex Shneider et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Neurocovid: Pharmacological recommendations for delirium associated with COVID-19

(2020) Erica B. Baller et al.   PSYCHOSOMATICS

Melatonin: Roles in influenza, Covid‐19, and other viral infections

(2020) George Anderson et al.   REVIEWS IN MEDICAL VIROLOGY

Delirium, sleep, COVID-19 and melatonin

(2020) Viroj Wiwanitkit   SLEEP MEDICINE

Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment

(2020) Virna Margarita Martín Giménez et al.   LIFE SCIENCES

COVID-19: Melatonin as a potential adjuvant treatment

(2020) Rui Zhang et al.   LIFE SCIENCES

Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific Societies

(2020) Laura Palagini et al.   Frontiers in Psychiatry

Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19

(2020) Russel J. Reiter et al.   Frontiers in Medicine

Delirium Assessment in Critically Ill Older Adults

(2020) Maria C. Duggan et al.   CRITICAL CARE CLINICS

Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19

(2020) Mohamed A. El-Missiry et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Melatonin potentials against viral infections including COVID-19: Current evidence and new findings

(2020) Kobra Bahrampour Juybari et al.   VIRUS RESEARCH

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

(2019) Sue Wilson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

(2018) Nava Zisapel   BRITISH JOURNAL OF PHARMACOLOGY

Insomnia in the Elderly: A Review

(2018) Dhaval Patel et al.   Journal of Clinical Sleep Medicine

Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content

(2017) Lauren A.E. Erland et al.   Journal of Clinical Sleep Medicine

Quality control and determination of melatonin in food supplements

(2016) Ana B. Cerezo et al.   JOURNAL OF FOOD COMPOSITION AND ANALYSIS

Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people

(2015) Emma L Arbon et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of prolonged-release melatonin and zolpidem on postural stability in older adults

(2012) Sarah Otmani et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

(2011) Nava Zisapel et al.   Therapeutics and Clinical Risk Management

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

(2009) Remy Luthringer et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

(2008) S. Otmani et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL